substance p has been researched along with Canine Diseases in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Calka, J; Gonkowski, S; Kaczmar, E; Makowska, K; Rychlik, A | 1 |
| Heikkilä, HM; Hielm-Björkman, AK; Innes, JF; Laitinen-Vapaavuori, OM | 1 |
| Asti, M; Bettini, G; Chiocchetti, R; Fracassi, F; Giancola, F; Pietra, M; Polidoro, G | 1 |
| Hayashida, K | 1 |
| Agnello, K; Brown, DC | 1 |
| Carr, MN; Koch, SN; Reiter, LV; Torres, SM | 1 |
| Constantino-Casas, F; Hu, HZ; Jeffery, N; Rusbridge, C | 1 |
| De Risio, L; Gandini, G; Goedde, T; Matiasek, K; Reese, S; Rosati, M; Steffen, F | 1 |
| Cummings, JF; de Lahunta, A; McDonald, JM; Simpson, ST | 1 |
| DeMora, F; Ferrer, L; García, G; Puigdemont, A | 1 |
| Brazís, P; de Mora, F; Ferrer, L; García, G; Majó, N; Puigdemont, A | 1 |
| Marsella, R; Nicklin, CF | 1 |
| Kitani, S; Mochizuki, M; Morita, Y; Nagase, M; Nishimura, R; Sasaki, N; Takahashi, T | 1 |
| Abrams, GA; Bentley, E; Campbell, S; Marfurt, CF; McDermott, A; Murphy, CJ; Reid, TW | 1 |
| Fujinaga, T; Ishiguro, T; Kadosawa, T; Mori, K; Okumura, M; Takagi, S | 1 |
| Marsella, R; Melloy, C; Nicklin, CF | 1 |
3 trial(s) available for substance p and Canine Diseases
| Article | Year |
|---|---|
The effect of intra-articular botulinum toxin A on substance P, prostaglandin E
Topics: Animals; Arthralgia; Botulinum Toxins, Type A; Dinoprostone; Dog Diseases; Dogs; Double-Blind Method; Female; Injections, Intra-Articular; Male; Osteoarthritis; Pain; Pain Management; Substance P; Synovial Fluid; Treatment Outcome; Tumor Necrosis Factor-alpha | 2017 |
Intrathecal substance P-saporin in the dog: efficacy in bone cancer pain.
Topics: Animals; Behavior, Animal; Bone Neoplasms; Dog Diseases; Dogs; Double-Blind Method; Injections, Spinal; Lameness, Animal; Motor Activity; Pain Measurement; Pain, Intractable; Prospective Studies; Ribosome Inactivating Proteins, Type 1; Saporins; Substance P; Treatment Outcome | 2013 |
The effects of capsaicin topical therapy in dogs with atopic dermatitis: a randomized, double-blinded, placebo-controlled, cross-over clinical trial.
Topics: Administration, Cutaneous; Animals; Capsaicin; Cross-Over Studies; Dermatitis, Atopic; Dog Diseases; Dogs; Double-Blind Method; Female; Male; Pruritus; Substance P; Treatment Outcome | 2002 |
13 other study(ies) available for substance p and Canine Diseases
| Article | Year |
|---|---|
Changes in the expression of substance P in nerve fibres of the colonic mucosa in dogs suffering from inflammatory bowel disease.
Topics: Animals; Colon; Dog Diseases; Dogs; Female; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Nerve Fibers; Substance P | 2020 |
Substance P and the neurokinin-1 receptor expression in dog ileum with and without inflammation.
Topics: Animals; Dog Diseases; Dogs; Enteric Nervous System; Female; Gene Expression; Ileum; Inflammation; Intestinal Mucosa; Male; Muscle, Smooth; Neurons; Nitrergic Neurons; Receptors, Neurokinin-1; Substance P | 2017 |
Substance P-saporin for bone cancer pain in dogs: can man's best friend solve the lost in translation problem in analgesic development?
Topics: Animals; Bone Neoplasms; Dog Diseases; Neurokinin-1 Receptor Antagonists; Pain, Intractable; Ribosome Inactivating Proteins, Type 1; Saporins; Spinal Cord; Substance P | 2013 |
Investigation of the pruritogenic effects of histamine, serotonin, tryptase, substance P and interleukin-2 in healthy dogs.
Topics: Analgesics, Non-Narcotic; Animals; Dog Diseases; Dogs; Female; Histamine; Histamine Agonists; Interleukin-2; Neurotransmitter Agents; Pruritus; Serotonin; Serotonin Agents; Substance P; Tryptases | 2009 |
Distribution of substance P and calcitonin gene-related peptide in the spinal cord of Cavalier King Charles Spaniels affected by symptomatic syringomyelia.
Topics: Animals; Calcitonin Gene-Related Peptide; Dog Diseases; Dogs; Spinal Cord; Substance P; Syringomyelia | 2012 |
Developmental changes in voltage-gated calcium channel α(2)δ-subunit expression in the canine dorsal root ganglion.
Topics: Animals; Biomarkers; Calcitonin Gene-Related Peptide; Calcium Channels, L-Type; Cell Size; Dog Diseases; Dogs; Forelimb; Ganglia, Spinal; Hindlimb; Immunoenzyme Techniques; Immunohistochemistry; Neuralgia; Neurons; Spinal Cord; Substance P | 2012 |
Reduced substance P-like immunoreactivity in hereditary sensory neuropathy of pointer dogs.
Topics: Animals; Dog Diseases; Dogs; Female; Hereditary Sensory and Autonomic Neuropathies; Histocytochemistry; Immunoenzyme Techniques; Spinal Cord; Substance P | 1984 |
Effect of H1-antihistamines on histamine release from dispersed canine cutaneous mast cells.
Topics: Animals; Calcimycin; Cell Survival; Cetirizine; Concanavalin A; Dermatitis, Atopic; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Histamine H1 Antagonists; Histamine Release; In Vitro Techniques; Ketotifen; Loratadine; Mast Cells; Skin; Substance P; Terfenadine | 1997 |
Comparative morphofunctional study of dispersed mature canine cutaneous mast cells and BR cells, a poorly differentiated mast cell line from a dog subcutaneous mastocytoma.
Topics: Animals; Calcimycin; Cell Separation; Concanavalin A; Dog Diseases; Dogs; Histamine; Histamine Release; In Vitro Techniques; Ionophores; Mast Cells; Mast-Cell Sarcoma; Microscopy, Electron; p-Methoxy-N-methylphenethylamine; Receptors, IgE; Substance P; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1998 |
Intradermal skin test reactivity to histamine and substance P is blunted in dogs with atopic dermatitis.
Topics: Animals; Case-Control Studies; Dermatitis, Atopic; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Female; Histamine; Intradermal Tests; Male; Pruritus; Skin; Substance P; Time Factors | 2001 |
IgG-mediated histamine release from canine mastocytoma-derived cells.
Topics: Animals; Calcimycin; Cell Line; Chymases; Dog Diseases; Dogs; Female; Histamine Release; Immunoglobulin G; Intestinal Neoplasms; Ionophores; Male; Mast Cells; Mast-Cell Sarcoma; Microscopy, Electron; Serine Endopeptidases; Skin Neoplasms; Substance P; Tryptases; Tumor Cells, Cultured | 2001 |
Spontaneous chronic corneal epithelial defects (SCCED) in dogs: clinical features, innervation, and effect of topical SP, with or without IGF-1.
Topics: Administration, Topical; Animals; Calcitonin Gene-Related Peptide; Chronic Disease; Corneal Diseases; Dog Diseases; Dogs; Drug Therapy, Combination; Epithelium, Corneal; Female; Fluorophotometry; Immunoenzyme Techniques; Insulin-Like Growth Factor I; Male; Substance P; Thiolester Hydrolases; Trigeminal Nerve; Tyrosine 3-Monooxygenase; Ubiquitin Thiolesterase; Vasoactive Intestinal Peptide | 2001 |
Establishment and characterization of a new canine mast cell tumor cell line.
Topics: Animals; Antibodies, Anti-Idiotypic; Calcimycin; Cell Division; Concanavalin A; Dog Diseases; Dogs; Histamine; Histocytochemistry; Ionophores; Male; Mastocytosis; Microscopy, Electron; Mouth Neoplasms; p-Methoxy-N-methylphenethylamine; Substance P; Tumor Cells, Cultured | 2001 |